These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1644895)

  • 1. Immunoregulatory mechanisms of the eye.
    Streilein JW; Wilbanks GA; Cousins SW
    J Neuroimmunol; 1992 Aug; 39(3):185-200. PubMed ID: 1644895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review.
    Streilein JW; Wilbanks GA; Taylor A; Cousins S
    Curr Eye Res; 1992; 11 Suppl():41-7. PubMed ID: 1424750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye.
    Cousins SW; Trattler WB; Streilein JW
    Curr Eye Res; 1991 Apr; 10(4):287-97. PubMed ID: 1906392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous humor factors and their effect on the immune response in the anterior chamber.
    Streilein JW; Cousins SW
    Curr Eye Res; 1990; 9 Suppl():175-82. PubMed ID: 2200643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
    Wilbanks GA; Streilein JW
    Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular immune privilege sites.
    Masli S; Vega JL
    Methods Mol Biol; 2011; 677():449-58. PubMed ID: 20941626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The eye's view of antigen presentation.
    Streilein JW; Masli S; Takeuchi M; Kezuka T
    Hum Immunol; 2002 Jun; 63(6):435-43. PubMed ID: 12039518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
    Streilein JW
    J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW; Ksander BR
    Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior chamber-associated immune deviation induced by soluble antigens.
    Mizuno K; Clark AF; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune regulation and the eye: a dangerous compromise.
    Streilein JW
    FASEB J; 1987 Sep; 1(3):199-208. PubMed ID: 2957263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imposing deviant immunity on the presensitized state.
    Kosiewicz MM; Okamoto S; Miki S; Ksander BR; Shimizu T; Streilein JW
    J Immunol; 1994 Oct; 153(7):2962-73. PubMed ID: 8089480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis.
    Takeuchi M; Alard P; Verbik D; Ksander B; Streilein JW
    Immunology; 1999 Dec; 98(4):576-83. PubMed ID: 10594691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye.
    Griffith TS; Herndon JM; Lima J; Kahn M; Ferguson TA
    Int Immunol; 1995 Oct; 7(10):1617-25. PubMed ID: 8562507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.